Success Metrics

Clinical Success Rate
87.5%

Based on 91 completed trials

Completion Rate
88%(91/104)
Active Trials
31(15%)
Results Posted
24%(22 trials)
Terminated
13(6%)

Phase Distribution

Ph early_phase_1
1
0%
Ph phase_1
5
2%
Ph phase_2
35
17%
Ph phase_4
9
4%
Ph phase_3
9
4%
Ph not_applicable
116
55%

Phase Distribution

6

Early Stage

35

Mid Stage

18

Late Stage

Phase Distribution175 total trials
Early Phase 1First-in-human
1(0.6%)
Phase 1Safety & dosage
5(2.9%)
Phase 2Efficacy & side effects
35(20.0%)
Phase 3Large-scale testing
9(5.1%)
Phase 4Post-market surveillance
9(5.1%)
N/ANon-phased studies
116(66.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.5%

91 of 113 finished

Non-Completion Rate

19.5%

22 ended early

Currently Active

31

trials recruiting

Total Trials

211

all time

Status Distribution
Active(41)
Completed(91)
Terminated(22)
Other(57)

Detailed Status

Completed91
unknown55
Recruiting21
Terminated13
Active, not recruiting10
Not yet recruiting10

Development Timeline

Analytics

Development Status

Total Trials
211
Active
31
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.6%)
Phase 15 (2.9%)
Phase 235 (20.0%)
Phase 39 (5.1%)
Phase 49 (5.1%)
N/A116 (66.3%)

Trials by Status

recruiting2110%
completed9143%
terminated136%
unknown5526%
active_not_recruiting105%
suspended21%
not_yet_recruiting105%
withdrawn94%

Recent Activity

Clinical Trials (211)

Showing 20 of 211 trialsScroll for more
NCT04522570Not Applicable

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Completed
NCT06732388Phase 2

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

Recruiting
NCT06553625

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Recruiting
NCT07778589Not Applicable

Comparison Between Radiofrequency,Hydrodissection and Cryoneurolysis in Chronic Ankle Pain

Not Yet Recruiting
NCT00180856Phase 2

Radiofrequency Ablation of Lung Tumors

Completed
NCT06253000Not Applicable

Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium

Recruiting
NCT05930756Not Applicable

3-point vs 6-point GNRFA for Chronic KOA

Withdrawn
NCT07612241

Pulsed Field Ablation Versus Radiofrequency Ablation: Effects of Pulmonary Vein Isolation Combined With Left Atrial Posterior Wall Isolation on Postoperative Gastric Motility in Patients With Persistent Atrial Fibrillation

Not Yet Recruiting
NCT05189821

RFA Treatment for Papillary Thyroid Microcarcinoma

Recruiting
NCT05189808

Radiofrequency Ablation for BIII Thyroid Nodules

Recruiting
NCT05189314

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

Recruiting
NCT02756754Not Applicable

Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism

Completed
NCT04673032

Radiofrequency (RF) Ablation Prospective Outcomes Study

Completed
NCT05666271

Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes

Active Not Recruiting
NCT06170736Not Applicable

Radiofrequency Ablation vs Doppler-guided Haemorrhoidal Artery Ligation in the Treatment of Haemorrhoidal Disease

Recruiting
NCT06863181Not Applicable

Comparison of Conventional and Cooled Radiofrequency Ablation in Knee Osteoarthritis

Completed
NCT06134752Not Applicable

Electroporation for Treatment of Atrial Fibrillation

Active Not Recruiting
NCT05952518Not Applicable

PNS vs RFA for Facet Joint Pain

Suspended
NCT05473663Not Applicable

Radiofrequency Ablation After Total Knee Arthroplasty

Active Not Recruiting
NCT02437071Phase 2

Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
211